$140K to advance Alzheimer’s detection in diverse populations
The research focuses on evaluating the effectiveness of the blood test for a specific biomarker of the disease.
The research focuses on evaluating the effectiveness of the blood test for a specific biomarker of the disease.
Approximately 23% of Alzheimer’s and related dementia cases in individuals aged 65 and older can be linked to controllable risk factors.
Researchers at the Myron B. Thompson School of Social Work wrote the story to explain the symptoms of Alzheimer’s disease and available support resources.
Robert Nichols and research collaborators observed that applying a smaller, non-toxic fragment taken from an already microscopic protein fragment called a “beta amyloid” peptide can actually protect the nerve cells and restore normal memory processing.
A clinical trial will begin on a drug that researchers hope will reduce inflammation in patients with mild-to-moderate Alzheimer’s Disease.
A study by UH Mānoa’s Linda Chang shows people with a specific variant of the apolipoprotein-E gene are more likely to develop Alzheimer’s disease.
Hawaiʻi is one of 11 states to receive grant from U.S. Department of Health and Human Services.